Serum selenium predicts levels of F₂-isoprostanes and prostaglandin F_2α in a 27 year follow-up study of Swedish men

References

• Salonen JT, Alfthan G, Huttunen JK, Pikkarainen J, Puska P. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet 1982;2:175–179.
   Google Scholar
• Suadicani P, Hein HO, Gyntelberg F. Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis 1992; 96:33–42.
   Google Scholar
• Neve J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk 1996;3:42–47.
   PubMedGoogle Scholar
• Alissa EM, Bahijri SM, Ferns GA. The controversy surrounding selenium and cardiovascular disease: A review of the evidence. Med Sci Monit 2003;9:RA9–R18.
   Google Scholar
• Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipo-protein that increase its atherogenicity. N Engl J Med 1989; 320:915–924.
   Google Scholar
• Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115–126.
   PubMed Web of Science ®Google Scholar
• Parnham MJ, Graf E. Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions. Biochem Pharmacol 1987;36:3095–3102.
   PubMed Web of Science ®Google Scholar
• Morrow JD, Hill KE, Burk RF, Nammour TM, Bath KF, Roberts LJD. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990;87:9383–9387.
   PubMed Web of Science ®Google Scholar
• Roberts LJ, Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000;28:505–513.
   PubMed Web of Science ®Google Scholar
• Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts U. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995;332: 1198–1203.
   Google Scholar
• Reilly MP, Pratico D, Delanty N, DiMinno G, Tremoli E, Rader D, Kapoor S, Rokach J, Lawson J, FitzGerald GA. Increased formation of distinct F2 isoprostanes in hyper-cholesterolemia. Circulation 1998;98:2822–2828.
   PubMed Web of Science ®Google Scholar
• Helmersson J, Vessby B, Larsson A, Basu S. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 2004109:1729-1734.
   PubMed Web of Science ®Google Scholar
• Helmersson J, Larsson A, Vessby B, Basu S. Active smoking and a history of smoking are associated with enhanced prostaglandin F2alpha, interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis 2005; in press.
   Google Scholar
• Basu S, Helmersson J. Factors regulating isoprostane formation in vivo. Antioxid Redox Signal 2005;7:221–235.
   PubMed Web of Science ®Google Scholar
• Vane JR. Prostaglandins as mediators of inflammation. Adv Prostaglandin Thromboxane Res 1976;2:791–801.
   PubMedGoogle Scholar
• Bergstrom S. Prostaglandins: Members of a new hormonal system. These physiologically very potent compounds of ubiquitous occurrence are formed from essential fatty acids. Science 1967;157:382–391.
   Google Scholar
• Samuelsson B. Prostaglandins, thromboxanes, and leuko-trienes: Formation and biological roles. Harvey Lect 1979–80; 75: 1–40.
   Google Scholar
• Mutschler DK, Eriksson MB, Wikstrom BG, Lind L, Larsson A, Bergren-Kiiski R, Lagrange A, Nordgren A, Basu S. Microdialysis-evaluated myocardial cyclooxygenase-mediated inflammation and early circulatory depression in porcine endotoxemia. Crit Care Med 2003;31:1780–1785.
   Google Scholar
• Basu S. Radioimmunoassay of 15-keto-13,14-dihydro-prosta-glandin F2alpha: An index for inflammation via cyclooxygen-ase catalysed lipid peroxidation. Prostag Leukotr Ess Fatty Acids 1998;58:347–352.
   PubMed Web of Science ®Google Scholar
• Basu S, Eriksson M. Oxidative injury and survival during endotoxemia. FEBS Lett 1998;438:159–160.
   PubMed Web of Science ®Google Scholar
• Basu S, Whiteman M, Mattey DL, Halliwell B. Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases. Ann Rheum Dis 2001;60:627–631.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circula-tion 2000101:1767-1772.
   PubMed Web of Science ®Google Scholar
• Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB. Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses. BMJ 2000;321:199–204.
   PubMed Web of Science ®Google Scholar
• Hedstrand H. A study of middle-aged men with particular reference to risk factors for cardiovascular disease. Ups J Med Sci Suppl 1975;19:1–61.
   PubMedGoogle Scholar
• Alfthan G, Kumpulainen J. Determination of selenium in small volumes of blood plasma and serum by electrothermal atomic absorption spectrometry. Analytica Chimica Acta 1982;140:221–227.
   Web of Science ®Google Scholar
• Basu S. Radioimmunoassay of 8-iso-prostaglandin F2alpha: An index for oxidative injury via free radical catalysed lipid peroxidation. Prostag Leukotr Ess Fatty Acids 1998;58: 319–325.
   PubMed Web of Science ®Google Scholar
• Helmersson J, Basu S. F2-isoprostane excretion rate and diurnal variation in human urine. Prostag Leukotr Ess Fatty Acids 1999;61:203–205.
   PubMed Web of Science ®Google Scholar
• Boberg M, Croon LB, Gustafsson IB, Vessby B. Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. Clin Sci (Lond) 1985;68:581–587.
   PubMed Web of Science ®Google Scholar
• Smedman AE, Gustafsson IB, Berglund LG, Vessby BO. Pentadecanoic acid in serum as a marker for intake of milk fat: Relations between intake of milk fat and metabolic risk factors. Am J Clin Nutr 1999;69:22–29.
   PubMed Web of Science ®Google Scholar
• Milne DB, Botnen J. Retinol, alpha-tocopherol, lycopene, and alpha- and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 1986;32:874–876.
   PubMed Web of Science ®Google Scholar
• Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids 2000;35:967–974.
   Google Scholar
• Gottschall EB, Wolfe P, Haegele AD, Zhu Z, Rose CS, Sells T, Thompson HJ. Increased urinary 8-isoprostaglandin F(2)alpha is associated with lower plasma selenium levels and lower vegetable and fruit intake in an asbestos-exposed cohort at risk for lung cancer. Chest 2004;125: 835.
   Google Scholar
• Awad JA, Morrow JD. Excretion of F2-isoprostanes in bile: A novel index of hepatic lipid peroxidation. Hepatology 1995;22:962–968.
   PubMed Web of Science ®Google Scholar
• Awad JA, Morrow JD, Hill KE, Roberts U, Burk RF. Detection and localization of lipid peroxidation in selenium-and vitamin E-deficient rats using F2-isoprostanes. J Nutr 1994;124: 810–816.
   Google Scholar
• Rayman MP. The importance of selenium to human health. Lancet 2000;356:233–241.
   PubMed Web of Science ®Google Scholar
• Salonen JT, Salonen R, Seppanen K, Kantola M, Parviainen M, Alfthan G, Maenpaa PH, Taskinen E, Rauramaa R. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men. Atherosclerosis 1988;70:155–160.
   Google Scholar
• Chang M, Burgess JR, Scholz RW, Reddy CC. The induction of specific rat liver glutathione S-transferase subunits under inadequate selenium nutrition causes an increase in prostaglandin F2 alpha formation. J Biol Chem 1990; 265:5418–5423.
   PubMed Web of Science ®Google Scholar
• Zamamiri-Davis F, Lu Y, Thompson JT, Prabhu KS, Reddy PV, Sordillo LM, Reddy CC. Nuclear factor-kappaB mediates over-expression of cyclooxygenase-2 during activation of RAW 264.7 macrophages in selenium deficiency. Free Radic Biol Med 2002;32: 890–897.
   Google Scholar
• Hong Y, Li CH, Burgess JR, Chang M, Salem A, Srikumar K, Reddy CC. The role of selenium-dependent and selenium-independent glutathione peroxidases in the formation of prostaglandin F2 alpha. J Biol Chem 1989; 264:13793–13800.
   Google Scholar
• Davi G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, Nutini M, Sensi S, Patrono C. Platelet activation in obese women: Role of inflammation and oxidant stress. JAMA 2002;288:2008–2014.
   Google Scholar
• Gniwotta C, Morrow JD, Roberts U, Kuhn H. Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1997;17:3236–3241.
   PubMed Web of Science ®Google Scholar
• FitzGerald GA, Austin S, Egan K, Cheng Y, Pratico D. Cyclo-oxygenase products and atherothrombosis. Ann Med 2000;32:21–26.
   Google Scholar
• Kilander L, Berglund L, Boberg M, Vessby B, Lithe11 H. Education, lifestyle factors and mortality from cardiovascular disease and cancer. A 25-year follow-up of Swedish 50-year-old men. hit J Epidemiol 2001;30: 1119–1126.
   Google Scholar
• Salonen JT, Salonen R, Seppanen K, Kantola M, Suntioinen S, Korpela H. Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis. BMJ 1991;302:756–760.
   PubMed Web of Science ®Google Scholar
• Kok FJ, de Bruijn AM, Vermeeren R, Hofman A, van Laar A, de Bruin M, Hermus RJ, Valkenburg HA. Serum selenium, vitamin antioxidants, and cardiovascular mortality: A 9-year follow-up study in the Netherlands. Am J Clin Nutr 1987;45:462–468.
   PubMed Web of Science ®Google Scholar
• Salvini S, Hennekens CH, Morris JS, Willett WC, Stampfer MJ. Plasma levels of the antioxidant selenium and risk of myocardial infarction among U.S. physicians. Am J Cardiol 1995;76:1218–1221.
   Google Scholar
• Reimund JM, Hirth C, Koehl C, Baumann R, Duclos B. Antioxidant and immune status in active Crohn's disease. A possible relationship. Chin Nutr 2000;19:43–48.
   Google Scholar
• Ford ES, Liu S, Mannino DM, Giles WH, Smith SJ. C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults. Eur J Chin Nutr 2003;57:1157–1163.
   Google Scholar
• Nichol C, Herdman J, Sattar N, O'Dwyer PJ, O'Reilly DSJ, Littlejohn D, Fell G. Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: Further evidence for a negative acute phase response? Chin Chem 1998;44:1764–1766.
   Google Scholar
• Maehira F, Luyo GA, Miyagi I, Oshiro M, Yamane N, Kuba M, Nakazato Y. Alterations of serum selenium concentrations in the acute phase of pathological conditions. Chin Chim Acta 2002;316:137–146.
   Google Scholar
• Becker W, Pearson M. Food habits and nutrient intake in Sweden 1997–98 Swedish: Kostvanor och näringsintag i Sverige. Metod och resultatanalys. Livsmedelsverket. Uppsala, Sweden: Swedish National Food Administration; 2002.
   Google Scholar